Relief from severe depression and suicidal ideation within hours: from synapses to symptoms

76bc30630ae474b3bd32289541e091c1 National Institute of Mental Health {"start": "2015-11-04T20:00:00", "end": "2015-11-04T21:00:00"} zaratec@mail.nih.gov

Carlos Zarate, M.D.
Zarate, Carlos, M.D. Senior Investigator

Dr. Zarate’s current research focus is on developing novel medications for treatment-resistant depression and bipolar disorder. His areas of expertise include biological and pharmacological aspects of mood disorders in adults. Dr. Zarate’s group conducts proof-of-concept studies utilizing novel compounds and biomarkers (magnetoencephalography [MEG] and polysomnography [PSG], positron emission tomography, functional MRI and magnetic resonance spectroscopy [MRS]) to identify potentially relevant drug targets and biosignatures of treatment response. A multidisciplinary translational research team conducts the research in the ETPB. In addition, the Branch provides training to develop the next generation of clinical translational researchers.

https://videocast.nih.gov/watch=17559 https://irp.nih.gov/pi/carlos-zarate